Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 416

1.

Faster clearance of sustained release verapamil in men versus women: continuing observations on sex-specific differences after oral administration of verapamil.

Krecic-Shepard ME, Barnas CR, Slimko J, Schwartz JB.

Clin Pharmacol Ther. 2000 Sep;68(3):286-92.

PMID:
11014410
[PubMed - indexed for MEDLINE]
2.

Population analyses of sustained-release verapamil in patients: effects of sex, race, and smoking.

Kang D, Verotta D, Krecic-Shepard ME, Modi NB, Gupta SK, Schwartz JB.

Clin Pharmacol Ther. 2003 Jan;73(1):31-40.

PMID:
12545141
[PubMed - indexed for MEDLINE]
3.

In vivo comparison of putative probes of CYP3A4/5 activity: erythromycin, dextromethorphan, and verapamil.

Krecic-Shepard ME, Barnas CR, Slimko J, Gorski JC, Wainer IW, Schwartz JB.

Clin Pharmacol Ther. 1999 Jul;66(1):40-50.

PMID:
10430108
[PubMed - indexed for MEDLINE]
4.

Verapamil stereoisomerism: enantiomeric ratios in plasma dependent on peak concentrations, oral input rate, or both.

Karim A, Piergies A.

Clin Pharmacol Ther. 1995 Aug;58(2):174-84.

PMID:
7648767
[PubMed - indexed for MEDLINE]
5.

Gender-specific effects on verapamil pharmacokinetics and pharmacodynamics in humans.

Krecic-Shepard ME, Barnas CR, Slimko J, Jones MP, Schwartz JB.

J Clin Pharmacol. 2000 Mar;40(3):219-30.

PMID:
10709150
[PubMed - indexed for MEDLINE]
6.

The effect of gender on the pharmacokinetics of verapamil and norverapamil in human.

Dadashzadeh S, Javadian B, Sadeghian S.

Biopharm Drug Dispos. 2006 Oct;27(7):329-34.

PMID:
16892180
[PubMed - indexed for MEDLINE]
7.

Verapamil metabolite exposure in older and younger men during steady-state oral verapamil administration.

Abernethy DR, Wainer IW, Anacleto AI.

Drug Metab Dispos. 2000 Jul;28(7):760-5.

PMID:
10859149
[PubMed - indexed for MEDLINE]
Free Article
8.

The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity.

Gorski JC, Vannaprasaht S, Hamman MA, Ambrosius WT, Bruce MA, Haehner-Daniels B, Hall SD.

Clin Pharmacol Ther. 2003 Sep;74(3):275-87. Erratum in: Clin Pharmacol Ther. 2004 Mar;75(3):249.

PMID:
12966371
[PubMed - indexed for MEDLINE]
9.

Pharmacokinetics of verapamil and norverapamil in patients with hypertension: a comparison of oral conventional and sustained release formulations.

Jørgensen NP, Walstad RA.

Pharmacol Toxicol. 1988 Aug;63(2):105-7.

PMID:
3186615
[PubMed - indexed for MEDLINE]
10.

The effect of rifampin administration on the disposition of fexofenadine.

Hamman MA, Bruce MA, Haehner-Daniels BD, Hall SD.

Clin Pharmacol Ther. 2001 Mar;69(3):114-21.

PMID:
11240975
[PubMed - indexed for MEDLINE]
11.

Disposition and pharmacologic effects of R/S-verapamil in patients with chronic atrial fibrillation: an investigation comparing single and multiple dosing.

Busse D, Fromm MF, Mörike K, Drescher S, Kühlkamp V, Eichelbaum M.

Clin Pharmacol Ther. 2001 May;69(5):324-32.

PMID:
11372000
[PubMed - indexed for MEDLINE]
12.
13.

Pharmacokinetics of verapamil and norverapamil from controlled release floating pellets in humans.

Sawicki W.

Eur J Pharm Biopharm. 2002 Jan;53(1):29-35.

PMID:
11777750
[PubMed - indexed for MEDLINE]
14.

Opposite effect of diabetes mellitus induced by streptozotocin on oral and intravenous pharmacokinetics of verapamil in rats.

Hu N, Xie S, Liu L, Wang X, Pan X, Chen G, Zhang L, Liu H, Liu X, Liu X, Xie L, Wang G.

Drug Metab Dispos. 2011 Mar;39(3):419-25. doi: 10.1124/dmd.110.035642. Epub 2010 Dec 6.

PMID:
21135265
[PubMed - indexed for MEDLINE]
Free Article
15.

Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.

Palma-Aguirre JA, Absalón-Reyes JA, Novoa-Heckel G, de Lago A, Oliva I, Rodríguez Z, González-de la Parra M, Burke-Fraga V, Namur S.

Clin Ther. 2007 Jun;29(6):1146-52.

PMID:
17692728
[PubMed - indexed for MEDLINE]
16.

Influence of food on the bioavailability of a sustained-release verapamil preparation.

Conway EL, Phillips PA, Drummer OH, Louis WJ.

J Pharm Sci. 1990 Mar;79(3):228-31.

PMID:
2338632
[PubMed - indexed for MEDLINE]
17.

Pharmacokinetic properties of S-adenosylmethionine after oral and intravenous administration of its tosylate disulfate salt: a multiple-dose, open-label, parallel-group study in healthy Chinese volunteers.

Yang J, He Y, Du YX, Tang LL, Wang GJ, Fawcett JP.

Clin Ther. 2009 Feb;31(2):311-20. doi: 10.1016/j.clinthera.2009.02.010.

PMID:
19302903
[PubMed - indexed for MEDLINE]
18.

Sustained-release verapamil: multiple-dose pharmacokinetic comparison of 120-mg and 240-mg tablets and the effect of halving a 240-mg tablet.

McEwen J, Durnin C, McMurdo ME, Moreland TA.

J Cardiovasc Pharmacol. 1989;13 Suppl 4:S57-9.

PMID:
2475689
[PubMed - indexed for MEDLINE]
19.

Pharmacokinetic properties of rosuvastatin after single-dose, oral administration in Chinese volunteers: a randomized, open-label, three-way crossover study.

Li Y, Jiang X, Lan K, Zhang R, Li X, Jiang Q.

Clin Ther. 2007 Oct;29(10):2194-203.

PMID:
18042475
[PubMed - indexed for MEDLINE]
20.

Single- and multiple-dose pharmacokinetic evaluation of oxycodone and naloxone in an opioid agonist/antagonist prolonged-release combination in healthy adult volunteers.

Smith K, Hopp M, Mundin G, Leyendecker P, Bailey P, Grothe B, Uhl R, Reimer K.

Clin Ther. 2008 Nov;30(11):2051-68. doi: 10.1016/j.clinthera.2008.11.008.

PMID:
19108793
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk